Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating magrolimab plus pembrolizumab in relapsed or refractory classic Hodgkin lymphoma has been terminated with results p…
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pediatric and young a…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating brentuximab vedotin in combination with bendamustine for Hodgkin lymphoma and anaplastic large cell lymphoma comp…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin)…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Phase 1 of CTX-8371 in Patients With Advanced Malignancies [Phase 1]
Phase 1 clinical trial evaluating CTX-8371 in patients with advanced malignancies, including Non-Small Cell Lung Cancer and Triple-Negative …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma [EARLY_Phase 1]
This early-phase trial update describes evaluation of PD-1 inhibitors after CD30 CAR T-cell therapy in patients with relapsed or refractory …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: First in Human, Dose Escalation, Dose Expansion Study of AUR105 [Phase 1]
AUR105 is Aurigene's first-in-human Phase 1 study with dose-escalation and dose-expansion cohorts in adults with solid tumors and lymphomas.…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a two-step reduced-intensity conditioning approach for bone marrow transplant in adults with hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors [NA]
This completed clinical trial evaluated the effectiveness and implementation of an electronic health record tool to assess heart health amon…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update. It evaluates a conditioning strategy using chemotherapy, total body irradiation, and post-transpl…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
This clinical trial investigates brentuximab vedotin and nivolumab, with or without ipilimumab, for relapsed or refractory Hodgkin lymphoma …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase Ib of L-NMMA and Pembrolizumab [Phase 1]
This completed Phase 1 trial evaluated the combination of L-NMMA with pembrolizumab across multiple cancers, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation [Phase 1]
This Phase 1 trial evaluated donor-derived anti-CD19 CAR-T cells in patients with recurrent or persistent B-cell malignancies after allogene…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study [NA]
Completed clinical trial evaluating a geriatric optimization plan to improve survival in older adults undergoing allogeneic hematopoietic ce…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders [NA]
This update reports the completed status of a trial assessing bone marrow and kidney transplant for patients with chronic kidney disease and…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
This clinical trial update indicates active recruitment for a longitudinal study on sexual and reproductive health in women with breast canc…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Impact of Respiratory Training in Lymphoma Survivors [NA]
A terminated clinical trial evaluating respiratory training in lymphoma survivors has posted results as of 2026-02-27. The study was sponsor…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pedia…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) [Phase 2]
This update presents safety and efficacy data from a Phase 2 study of pembrolizumab (Keytruda) in children and young adults with classical H…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204) [Phase 3]
This update reports the completion of a Phase 3 trial (MK-3475-204/KEYNOTE-204) comparing pembrolizumab to brentuximab vedotin in relapsed o…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL [Phase 3]
This entry notes the completion of a Phase 3 trial investigating a treatment strategy driven by early PET response in Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes engineered to express a CD30 chimeric receptor for CD30-positive Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety and efficacy of combining favezelimab (MK-4280) with pembrolizumab (MK-3475) in patients wi…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies [Phase 1]
A Phase 1 trial evaluating flotetuzumab for relapsed or refractory CD123-positive hematologic malignancies has completed, providing initial …